A Caspase Inhibitor in Chronic Hepatitis C (HCV) Patients

Clinical trial NCT00088140 · COMPLETED

Trial details

NCT number: NCT00088140
Sponsor: Conatus Pharmaceuticals Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatitis C, Chronic

Start date: 2004-07-01
Primary completion: 2005-10-01
Enrollment: 204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.